Uterocervical Angle in the Pregnancy Termination of Multiparous Women

March 3, 2018 updated by: Berna Aslan Cetin, Kanuni Sultan Suleyman Training and Research Hospital

Uterocervical Angle in the Termination of Second Trimester Pregnancy in Multiparous Women

To evaluate the uterocervical angle (UCA) in the prediction of second trimester termination success of multiparous women.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Medical termination of pregnancy is a common procedure in obstetrics. In recent years, uterocervical angle (UCA) emerged as a new ultrasound parameter in the prediction of labor. Dziadosz et al concluded that the performance of UCA was even better than the cervical length in their cohort. A wide UCA during second trimester shown to have an increased risk of preterm labor and narrow angle was less likely to have labor.

The investigators are aimed to investigate predictive role of both cervical length and UCA in the termination of second trimester pregnancy.The investigators focused on multiparous women who are taking Foley baloon for the cervical preparation and aim to measure their UCA.

Study Type

Observational

Enrollment (Actual)

148

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Kanuni SSTRH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Multiparous pregnant women undergoing medical abortion in the second trimester

Description

Inclusion Criteria:

  • multiparous singleton pregnancy
  • no previous systemic illnesses

Exclusion Criteria:

  • abnormal Pap smear
  • history of dilatation and curettage (D&C)
  • history of LEEP and cervical conization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Medical abortion
150 singleton multiparous patients are planning to complete the study period. Study group constitute of second trimester pregnancies between 14-24 weeks of gestation. All participants were multiparous and had no systemic illnesses. The uterocervical angle will be measured in all participants before the induction of labor.
Other: uterocervical angle
the angle between cervical canal and anterior uterine wall is measured sonographically.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
uterocervical angle
Time Frame: 1 week
the angle between the cervical canal and anterior uterine wall
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2017

Primary Completion (ACTUAL)

January 31, 2018

Study Completion (ACTUAL)

February 1, 2018

Study Registration Dates

First Submitted

January 6, 2018

First Submitted That Met QC Criteria

January 12, 2018

First Posted (ACTUAL)

January 17, 2018

Study Record Updates

Last Update Posted (ACTUAL)

March 6, 2018

Last Update Submitted That Met QC Criteria

March 3, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2016/12.5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical; Abortion, Fetus

Clinical Trials on uterocervical angle

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe